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t he human genome contains over 20,000 genes and a larger number of regulatory elements. Large-scale studies over the last decade have catalogued these components of our genome and the cell 
types in which they are active. The ENCODE, Roadmap Epigenome, 
International Human Epigenome Consortium, EpiGeneSys (http://www.
epigenesys.eu/en/) and FANTOM projects1–4 have annotated thousands 
of genes and millions of candidate regulatory elements. However, our 
understanding of the mechanisms by which these elements exert regula-
tory effects on specific target genes across distances of kilobases, and in 
some cases megabases, remains incomplete.
The spatial folding of chromosomes and their organization in the 
nucleus have profound effects on gene expression. For example,  spatial 
proximity is necessary for enhancers to modulate transcription of  target 
genes (for example, refs 5–7), and clustering of chromatin near the nuclear 
lamina is correlated with gene silencing and replication timing8,9. In 
 addition, genome-wide association studies have identified large  numbers 
of disease-associated loci, and the majority of these loci are located in 
distal, potentially regulatory, noncoding regions (for  example, ref. 10). 
In cancer cells, genomic rearrangements frequently occur and these 
are at least in part guided by the three-dimensional organization of the 
nucleus11,12. These data emphasize the importance of distal elements 
for gene regulation and suggest an exciting opportunity to uncover the 
fundamental mechanisms of disease through the mapping of long-range 
chromatin interactions and three-dimensional genome organization. 
Therefore, to determine how the genome operates, we need to understand 
not only the linear encoding of information along chromosomes, but also 
its three-dimensional organization and its dynamics across time, that is, 
the ‘4D nucleome’. Concomitantly, we must pursue deeper  knowledge 
of the biophysical and molecular factors that determine genome 
 organization, and how this organization contributes to gene regulation 
and other nuclear activities. Here we outline the goals and strategies of the 
4D Nucleome (4DN) Network. This Network builds on other consortia 
and efforts focusing on (epi-)genome analysis outlined above and adds 
spatial and temporal dimensions to explore how the genome is organized 
inside cells and how this relates to genome function.
The nucleus is not a homogeneous organelle, but consists of distinct 
nuclear structures and non-chromatin bodies as well as defined chromo-
somal regions, such as centromeres, telomeres and insulator bodies, that 
have been shown to cluster with each other and other genomic regions to 
define distinct nuclear compartments13,14. Examples of nuclear structures 
include the nuclear lamina and nuclear pores. Examples of nuclear com-
partments include the heterochromatic compartment, while examples of 
nuclear bodies include nucleoli, nuclear speckles, paraspeckles, and Cajal 
and PML (promyelocytic leukaemia) bodies. Chromosome conformation 
capture (3C) approaches15,16 have yielded additional insights by char-
acterizing genome-wide chromatin folding at kilobase resolution6,17,18. 
These studies have shown that the genome is compartmentalized in active 
and inactive spatial compartments at the scale of the nucleus, and that 
within each compartment, folding of chromatin fibres brings together loci 
and regulatory elements that are otherwise separated by large genomic 
distances. CTCF, the cohesin complex and other DNA-binding proteins, 
as well as RNAs, have roles in organizing chromatin domains and long-
range interactions between DNA loci18–24. These studies indicate that the 
genome is intricately organized within the nucleus and that this organi-
zation has a critical role in gene regulation and activity.
During the past decade marked innovation in chromosome and 
nuclear structure analysis has occurred. Genomic approaches for 
mapping chromatin interactions, such as 3C, 4C (circular 3C, or 3C-on-
chip), 5C (3C-carbon copy), Hi-C, and chromatin-interaction analysis 
by paired-end-tag sequencing (ChIA-PET)16, are yielding genome-wide 
chromatin interaction maps at unprecedented resolution. Live-cell and 
super-resolution microscopic approaches, combined with application of 
new ways (for example, CRISPR–Cas9-based systems) to visualize loci 
and sub-nuclear structures are beginning to provide detailed views of the 
organization and dynamics of chromatin inside (living) cells25–31. There 
has also been pronounced progress in analysing chromosome structural 
data, producing structural models for chromosome folding32,33. However, 
despite this progress, a comprehensive understanding of the 4D nucleome 
is still lacking. This is partly due to the fact that different experimental cell 
systems and approaches are used that together with the absence of shared 
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benchmarks for assay performance have led to observations that cannot 
be directly compared. Additionally, we currently have limited  ability to 
integrate different data types (for example, chromatin interaction data 
and imaging-based distance measurements) and lack approaches that 
can measure and account for cell-to-cell variability in chromosome 
and nuclear organization. Finally, we lack mechanistic insights into the 
 relationships between chromosome conformation and nuclear processes, 
including transcription, DNA replication and  chromosome segregation. 
These gaps in our knowledge can be addressed by a highly  synergistic, 
multidisciplinary and integrated approach in which groups with  different 
expertise and knowledge, ranging from imaging and genomics to 
 computer science and physics, work closely together to study common 
cell systems using complementary methods.
Goals and strategy of the project
The 4DN Network will develop a set of approaches to map the structures 
and dynamics of the genome and to relate these features to its biological 
activities. The Network aims to generate quantitative models of nuclear 
organization in diverse cell types and conditions, including in single 
cells. Overall, we anticipate that these efforts will lead to new mechanistic 
insights into how the genome is organized, maintained, expressed and 
replicated, in both normal and disease states.
The 4DN Network will (1) develop, benchmark, validate and standardize 
a wide array of technologies to analyse the 4D nucleome; (2) integrate, 
analyse and model datasets obtained with these technologies to obtain 
a comprehensive view of the 4D nucleome; and (3) investigate the func-
tional role of various structural features of chromosome organization in 
transcription, DNA replication and other nuclear processes. These three 
main components are illustrated in Fig. 1.
To achieve these objectives, we have defined the following key steps. 
First, a set of common cell lines will be studied to enable direct cross- 
validation of data that are obtained with different methods (Table 1). 
Important criteria include a stable, haplotype-phased and normal 
 karyotype, ease of growth, ease of genome editing and suitability for 
(live-cell) imaging. Furthermore, given that cell populations are char-
acterized by cell-to-cell variation in their biological state (for example, 
cell-cycle stage), it will be important to use clonal cell populations that 
can be  synchronized, activated, induced or differentiated in a controlled 
manner.
Second, standards for data formats and quality will be established 
so that data can be shared broadly. This includes defining metrics for 
reproducibility and assessment of the sensitivity, specificity, resolution 
and precision with which aspects of the 4D nucleome can be measured.
Third, computational and analytical tools will be developed to  analyse 
individual datasets and to integrate, compare and cross-validate data 
obtained with different technologies. Importantly, they will enable the 
integration of the diverse datasets necessary to build comprehensive 
 models of the 4D nucleome.
Fourth, genetic, biochemical and biophysical approaches will be 
 developed to measure and perturb the roles of DNA sequences and 
trans-acting factors (proteins, RNA) in the formation of local and global 
aspects of the 4D nucleome and their impact on transcription and other 
nuclear functions.
Fifth, a common vocabulary will be developed to describe nuclear 
 features and biophysically derived principles guiding chromosome 
 folding. This is important, because currently, different structural descrip-
tions and interpretations have been used to describe features detected by 
different technologies, or even by the same methods. We need better and 
more precise descriptions of the underlying state of structural features that 
make up the 4D nucleome, for example, loops and domains, and develop 
a consistent terminology for when these features are detected by different 
technologies. This can be achieved by integrated analysis of data that will 
be obtained with a wide range of technologies that are used and under 
development by the Network.
A major goal is to compare and integrate the wealth of information 
that is anticipated to be generated by the Network. This will enable both 
benchmarking of experimental and computational approaches and better 
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Figure 1 | The 4D Nucleome project. The project encompasses three 
components. a, Experimental mapping approaches are used to measure 
a range of aspects of the spatial organization of the genome, including 
chromatin loops, domains, nuclear bodies and so on. b, Computational 
and modelling approaches are used to interpret experimental observations 
and build (dynamic) spatial models of the nucleus. c, Perturbation 
experiments, for example, using CRISPR–Cas9-mediated genome 
engineering, are used for functional validation. In these studies chromatin 
structures are altered, for example, by removing chromatin loops, creating 
novel loops at defined positions or tethering regulatory components in 
selected regions to test their architectural function. These perturbation 
studies can be complemented with functional studies, for example, analysis 
of gene expression to assess the functional implications of chromatin 
folding. The nucleus image (a) shows live cell CRISPR labelling of specific 
loci on human chromosomes 1 and 13 and is provided by H. Ma and 
T. Pederson.
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conformation capture data on the one hand and imaging on the other 
hand) reveals about the structure, dynamics and cell-to-cell variation in 
folding of chromosomes. The Network will analyse a small set of common 
cell lines (Table 1) and select a set of loci that will be studied using the 
wide array of technologies already employed or under development in the 
Network. A joint analysis group with members from across the Network 
will integrate and analyse this diverse dataset to produce benchmarks 
for each methodology, produce models that represent the folded state of 
chromosomes and how this is dynamic in real time and variable between 
cells, and determine how the chromosomal folding state relates to gene 
regulation.
Finally, to facilitate rapid dissemination of data to the larger scientific 
community, a shared database and a public 4DN data browser will be 
established which includes all data, detailed protocols, engineered cell 
lines and reagents used across the Network.
Structure of the 4DN Network
The 4DN Network encompasses several related efforts (http://www. 
4dnucleome.org/). First, six centres make up the Nuclear Organization 
and Function Interdisciplinary Consortium (NOFIC). These  centres 
will develop genomic and imaging technologies, and implement com-
putational models to understand the 4D nucleome. NOFIC  centres will 
work together with other components of the Network to  benchmark 
 experimental and computational tools, and to identify the most 
 appropriate repertoire of methods to study the 4D nucleome. These 
 studies will be combined with structural and functional validation 
of observations and models. Ultimately, the NOFIC aims to deliver 
 integrated approaches that can be used for the generation of a first draft 
of a model of the 4D nucleome.
Second, ongoing technological development is addressed by the 4DN 
Network in three ways. (1) New genomic interaction technologies will be 
developed to study the 4D nucleome at the single-cell level, to analyse the 
roles of RNA in chromatin architecture and to engineer new chromatin 
interactions. (2) New imaging and labelling methods are developed to 
visualize the genome at a high resolution, in live cells as well as in tissues, 
and in relation to genome activity. Chromatin dynamics will be assayed 
at high resolution over time scales of seconds to minutes (for example, 
mitotic compaction, transcription), hours (cell cycle) and days (differ-
entiation). (3) New methods will be developed to probe the DNA, RNA 
and protein composition of subnuclear structures such as the nuclear 
envelope and the nucleolus.
Third, a Data Coordination and Integration Center (DCIC; 
http://dcic.4dnucleome.org/) stores all the data that will be generated 
by the Network and coordinates data analysis. The DCIC will  maintain 
a website to share data and models with the Network and the larger 
 scientific community. An Organizational Hub (OH) coordinates activities 
across all 4DN centers and teams, manages the 4DN Opportunity 
Pool (4DN-OP) of funds, and maintains the 4DN web portal (https://
www.4dnucleome.org/), which releases all 4DN network generated 
resources including data (through DCIC), experimental protocols, data 
analysis protocols, software, cell line information, and educational mate-
rials. OH will also release 4DN-OP grant opportunities and application 
procedures through the web portal.Finally, a 4DN Network Outreach/
Education Working Group works in collaboration with the OH to 
increase the visibility of the 4DN Network and its associated resources, 
and foster interactions and collaborations with the larger biomedical 
community.
Research plans
The Network uses and develops a wide range of experimental technolo-
gies to study the organization of the genome and the nucleus, and a set 
of computational approaches to analyse the data and to start to build 
 models of the 4D nucleome. Further experiments include testing the 
causal roles and functional consequences of chromosome folding for 
genome  regulation. Below we describe these efforts in more detail.
Genomic technologies to reveal the 4D nucleome
3C technologies have been developed to examine long-range inter-
actions across the genome15,16. Genome-wide 3C technologies, for 
example, Hi-C, have revealed patterns of interactions that define 
genome structures at various resolutions, including loops and topo-
logically  associating domains (TADs)17,18,34,35. TADs can be hundreds of 
kilobases in size, often containing several genes and multiple enhancers, 
at least some of which appear to interact by looping mechanisms. The 
ChIA-PET method provides a finer resolution to detect structures 
defined by architectural proteins, such as CTCF and cohesin, as well 
as enhancer–promoter interactions associated with RNAPII and other 
transcription factors6. Furthermore, genome-wide mapping at base-
pair resolution to detect haplotype specific interactions are in pro-
gress, which will enable the connection of chromatin topology to the 
vast genetic information regarding complex traits and diseases. The 
Network will continue to develop 3C-based technologies, including 
genome-wide methods that enable the exploration of higher-order 
(beyond pairwise) DNA contacts, detection of chromatin interactions 
in (thousands of) individual cells36, and mapping of RNA–DNA inter-
actions (Table 2).
A limitation of current 3C methods is that they depend on a single 
crosslinker, formaldehyde, which has known biases in the type of resi-
dues it can crosslink. Because of the nature of formaldehyde, which is 
known to polymerize and crosslink molecules across a large range of 
distances, this approach lacks precise distance information. The Network 
will explore bivalent photo-activated crosslinkers that are separated by 
linkers of defined length and flexibility. 
Imaging the 4D nucleome
4DN investigators will develop and integrate imaging platforms that 
 enable visualizing the dynamics, interactions and structural organization 
of the nucleus at unprecedented temporal and spatial resolutions (Table 3). 
Each of these approaches has unique and complementary abilities for 
Table 1 | Common cell lines used by the 4DN Network
Tier 1 Description Availability
H1-ESC (WA01) Human embryonic stem cells 
(male)
WiCell




IMR90 Primary lung fibroblasts (female) ATCC
GM12878 EBV-immortalized B-lymphocytes 
(female)
Coriell
Tier 2 Description Availability
F121-9 Mouse Cast-129 F1 hybrid  
embryonic stem cells (female)
Gilbert laboratory, 
FSU
F123 Mouse C57BL/6N inbred 
embryonic stem cells (male)
Ren laboratory, 
UCSD
JM8.N4 Mouse Cast-129 F1 hybrid  
embryonic stem cells (male)
KOMP/UC Davis
H9-ESC (WA09) Human embryonic stem cells 
(female)
WiCell
hTert-RPE hTert-immortalized retina  
pigmented epithelium cells 
(female)
ATCC
K562 Chronic myelogenous leukaemia 
cells (female)
ATCC
HEK293 Human embryonic kidney cells 
(likely female)
ATCC
U2-OS Osteosarcoma cells (female) ATCC
HAP1 Haploid derivative of chronic  
myelogenous leukaemia (CML) cell 
line KBM-7 (male)
van Steensel  
laboratory, NKI




HCT116 Human colorectal carcinoma ATCC
Tier 1 cells are used for all studies, whereas Tier 2 cell lines are used for specific projects.  
ATCC; American Type Culture Collection; FSU, Florida State University; NKI, Netherlands Cancer 
Institute; UCSD, University of California San Diego; UCSF, University of California San Francisco; 
UMMS, University of Massachusetts Medical School.
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the analysis of different aspects of genome organization. In particular, 
platforms enabling live-cell imaging allow the dynamics of select 
 chromatin regions and nuclear features to be studied in real time 
(seconds to hours).
Standard and high-throughput fluorescent in situ hybridization (FISH) 
using oligonucleotide probes or guide RNA-mediated recruitment of 
fluorescently labelled dCas9 (CASFISH31) in fixed cells will be exploited 
to image genomic interactions over different spatial distances in different 
cell types and states. These imaging tools will have an important role 
in benchmarking, validating and complementing data obtained with 
genomic and proteomic mapping technologies. CRISPR–dCas9 FISH 
in live cells29,30,38 and other live-cell imaging approaches (Table 3) will 
be used to assay the dynamic behaviour of particular chromatin regions 
and/or nuclear structures in real time.
New technologies will be developed to label DNA, RNA and proteins 
that occur in proximity of specific nuclear bodies. These proximity 
mapping technologies include the use of horseradish peroxidase (HRP)-
labelled antibodies for tyramide signal amplification–sequencing 
(TSA–seq) (Table 2), APEX (engineered ascorbate peroxidase39) for 
electron microscopy and live cell proteomic fingerprinting and the 
photosensitizer, Killer Red40, for free radical generation within nuclear 
microenvironments. Genome-editing technologies will also be applied 
to tag a subset of key genomic loci, loops, TADs and  potentially newly 
discovered structures to help visualize these moieties and document their 
interactions with other nuclear regions in live cells.
Super-resolution microscopy, single-molecule tracking techniques and 
multiplex fluorescent/chemical tags will be used in living cells to deter-
mine the dynamic interactions, diffusion and motion of fluorescently 
labelled proteins, non-coding RNA (ncRNA) and genomic loci (Table 3). 
These live-cell imaging approaches are expected to provide information 
regarding the search mechanism, binding and residence time of DNA 
and protein interactions and will also be used to validate and complement 
genomic methods used by the Network.
Soft X-ray tomography (SXT41) will be used to visualize the 3D organ-
ization of chromatin in nuclei of cells in the native state (cryo-immobi-
lized). SXT will be used to directly measure chromatin compaction, for 
example, in relation to sub-nuclear position, at different stages of the cell 
cycle, during differentiation and in different cell types. Correlated micro-
scopy approaches will be used to augment ultrastructural data with molec-
ular localization information. Cryogenic fluorescence tomography (CFT42) 
will be used to precisely locate molecules in three-dimensional reconstruc-
tions of intact cells in their native state that are imaged using SXT.
Members of the Network will develop new electron microscopy (EM) 
technologies that enable the local and global structural organization of 
chromatin to be visualized as a continuum from nucleosome to Mb scale in 
both interphase and mitotic cells. One such method, chrom-EMT43, will be 
combined with new genetic tags and nanoparticle-labelling technologies to 
develop the electron microscopy equivalent of ‘multi-colour’ fluorescence.
The development of automated imaging analysis pipelines and data 
standards will be important to extract the maximum structural infor-
mation possible from these datasets. Further development of software 
for analysing, annotating and archiving imaging data, together with 
 implementation of new approaches for correlating imaging and genomics 
datasets are major goals of the 4DN Network (see below).
Nuclear bodies and non-chromatin structures
The nucleus consists of distinct nuclear structures, such as the nuclear 
lamina and nuclear pores, chromatin-associated bodies, such as  nucleoli 
Table 2 | Genomic technologies currently in use or in development in the 4DN Network
Assay Name Assay Abbreviation Key features
Chromosome Conformation Capture 3C15,61 Interactions between specific genomic loci, including genome-wide studies
4C62 Genome-wide interactions of a specific genomic locus
5C63 Many loci against many loci
Hi-C17 Genome-wide map of all interactions in the nucleus
Single-cell Hi-C36 Hi-C variant that enables mapping contacts within single cells
Combinatorial single-cell Hi-C64 Single-cell Hi-C variant using split-pool barcoding to map single cells
In situ Hi-C64 Hi-C variant that performs digestion and ligation in intact nuclei
DNase Hi-C65 Hi-C variant that digests chromatin using DNase
Micro-C66,67 Hi-C variant that digests chromatin using micrococcal nuclease
Capture Hi-C68,69 Hi-C variant that incorporates selection of targeted genomic loci
TCC70 A variant of Hi-C using bead-coupling of complexes
Distance Hi-C (UD) Variant of Hi-C using photo-activated crosslinkers to measure the distance 
between interacting DNA regions.
COLA71 A variant of Hi-C using frequent restriction cutters to map > 2 simultaneous 
DNA interactions
Chromatin-interaction analysis by paired- 
end-tag sequencing
ChIA-PET6,72 Genome-wide map of interactions bound to a specific protein
Genome architecture mapping GAM37 A cryosectioning method to map colocalized DNA regions in a ligation- 
independent manner
Split-pool barcoding of RNA and DNA SPRITE A ligation-independent method to barcode interacting RNA and DNA that 
enables mapping of higher-order contacts
RNA interaction with chromatin by  
paired-end-tag sequencing
RICh-PET (UD) Genome-wide mapping for all ncRNA-chromatin interactions
Chromatin-immunoprecipitation aided  
RICh-PET
ChIP RICh-PET, UD Genome-wide mapping for three-way interactions involving ncRNA, DNA loci 
and protein factors
DNA adenine methyltransferase identification DamID and Single-Cell 
DamID8,73
Genome-wide mapping of molecular contact frequency of DNA loci to a 
Dam-methylase fusion protein: will be used to measure DNA proximity to 
different nuclear compartments
Tyramide signal amplification–sequencing TSA–seq (UD) Genome-wide mapping of estimated mean cytological distance (in μ m) of a 
DNA locus in a nuclear compartment
Replicated DNA sequencing Repli–seq74,75 Genome-wide mapping of the timing of DNA replication
Thousands of reporters integrated in parallel TRIP51 Genome-wide mapping of chromosome position effects on transcription and 
post-transcriptional processing
RNA antisense purification RAP49,50,76,77 Mapping of DNA regions, RNA species and proteins that are in proximity to a 
specific ncRNA in the nucleus
UD, under development; SPRITE, split pool recognition of interactions by tag extension
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that are initiated at specific genomic loci, as well as non-chromatin 
bodies, such as nuclear speckles, and PML bodies44,45. Increasing evidence 
indicates that specific genomic regions associate with these structures, 
suggesting that these chromosomal associations may have a functional 
role in regulating genome function8,46,47.
Goals of the 4DN Network further include development of new 
 mapping methodologies to measure the genome-wide molecular inter-
action frequency and cytological distance of chromosome loci to major 
nuclear compartments, including the nuclear lamina, nuclear pores, 
nuclear speckles, nucleoli and pericentric heterochromatin (Table 2). 
Concurrently, new and improved technologies will be developed, 
 including localized APEX-mediated protein biotinylation48, fractionation 
by cryomilling and RNA antisense purification (RAP49,50), to catalogue 
and measure the protein and RNA components of these nuclear compart-
ments, as well as both optogenetic and degron-based approaches to alter 
or disrupt sub-nuclear bodies and compartments. Functional mapping 
approaches based on replicated DNA sequencing (Repli–seq)9 and TRIP 
(thousands of reporters integrated in parallel)51 will provide genome-
wide correlations of DNA-replication timing and effects of chromosome 
position on transcription and RNA processing that can be correlated 
with these structural maps (Table 2). New imaging approaches will be 
developed to correlate chromosome and nuclear compartment dynamics 
with changes in DNA-replication timing, transcriptional activation and 
other functional states (Table 3). Computational analyses of these genome 
mapping data from several cell types will be aimed at identifying possible 
cis- and trans-determinants of nuclear compartmentalization.
Modelling the 4D Nucleome
In parallel with the emergence of increasingly powerful experimental 
methods has been the development of computational approaches for 
modelling the spatial organization of the genome. There are at least two 
major computational approaches for modelling genome architecture on 
the basis of experimental data: data-driven and de novo approaches33 
(Fig. 2). Data-driven approaches directly use experimental data 
(Hi-C, imaging, and so on) to produce an ensemble of conformations that 
best match an experimentally observed set of contact probabilities and 
distances52,53. De novo modelling, on the other hand, produces  ensembles 
of conformations that result from known or hypothesized physical or 
 biological processes, and tests whether these ensembles are consistent 
with features of experimental contact frequency maps and imaging 
data (for example, refs 19, 54). Such de novo models can suggest specific 
 molecular mechanisms and principles of chromosome organization, 
and can be predictive of chromosome dynamics and therefore can go far 
beyond the experimental data33.
There are several challenges and promises of current modelling 
approaches. The first is in a wide diversity of technologies that capture 
Table 3 | Imaging technologies currently in use or in development in the 4DN Network
Application Method (PMID) Label/stain/dye Feature
Visualizing DNA and 
RNA sequences
3D DNA and RNA FISH78, seqFISH79, 
MERFISH80,81
Fl-labelled oligo and BAC probes Fixed cells, single- and multiple-target DNA 
and RNA detection
HIPMap82 Fl-labelled probes High-throughput FISH and automated  
microscopy in fixed cells
CASFISH31,83, CRISPRainbow29,  
Cas live-cell imaging30,38
Fl-labelled dCas9 and guide RNAs (gRNAs) 
to label genomic loci; gRNAs can contain 
a stem loop bound by Fl-labelled coat 
proteins
Live and fixed cells–gRNAs against repetitive 
targets and/or collections of gRNAs that cover 
unique sequences
Track first, identify later84 Barcoded Fl-labelled oligos and Fl-dCas9 Combination of SeqFISH and Cas9 live-cell 
imaging
MS2, PP7, mSpinach, aptamers85,86 Fl-fusions that bind tagged RNA sequences Live and fixed cells: transcription
ParS-, LacO- or TetO-labelled genomic 
loci87,88
Visualized by Fl-labelled ParB-, lac- or tet- 
repressor proteins
Live and fixed cells: genomic tags
High resolution 
ultrastructure and 3D 
organization
Transmission EM, SBEM, multiple-tilt89 
and serial-section EM tomography90
Heavy metals, colloidal nanogold, inorganic 
and organic probes and tags, ChromEM, 
Alexa 633, Fluoronanogold, Time-STAMP-
YFP-MiniSOG
High resolution ultrastructure of  
macromolecules in situ ranging from 2D  
transverse projections through 70–250-nm 
sections to reconstruction of large 3D volumes 
(250 to > 500 nm thick)
Multi-colour EM91, ChromEMT (UD)43 Orthogonal-correlated light and EM probes 
and DAB conjugates
Local ultrastructure and global 3D organization 
of chromatin as a continuum at nucleosome 
resolutions and megabase scales
X-ray tomography41 Quantitative LAC-generated contrast that 
reflects the bioorganic composition of  
unlabelled DNA, RNA and proteins
Mesoscale resolution (20–50 nm) in intact, 
unprocessed cells
Correlated SIM and X-ray tomography42 Fl-labelled probes Visualize ultrastructure and interactions of 
selectively labelled chromatin and protein 
simultaneously
Visualizing spatial 
and dynamic 3D 
nuclear organization
Wide-field, confocal/multiphoton Fl probes: Fl protein, SNAP and Halo 
genomic tags, Alexa and Cy dyes, atto488, 
Suntag, SH2, Quantum dots, Janelia fluor 
dyes101
Live and fixed cells: diffraction limited  
(> 250 nm)
Super resolution: 3D SIM, PALM, 
STORM92, STED, adaptive optics93, 
tcPALM28, SAIM94
Fl probes, photo-activatable and  
photo-switchable proteins; caged organic 
fluorophores101 and organic fluorophores in 
thiol buffer coupled to SNAP, Halo,  
nanobodies or FISH oligos
Super-resolution imaging of nuclear  
organization in live and fixed cells  
(circa 10–20 nm)
LLS, LLS-PAINT95,96 Fl-labelled probes Live cell: 3D dynamics and nuclear  
organization
Single-molecule imaging and  
tracking97–100
Fl-labelled and photo-activatable probes, 
ArrayG
Live cell: binding and search dynamics:  
residence time, search time, search  
mechanism
BAC, bacterial artificial chromosome; CasFISH, CRISPR-associated protein 9 (Cas9) fluorescence in situ hybridization; CRISPRainbow, multiplexed labelling of genomic loci with dCas9 and engineered 
sgRNAs; DAB, 3,4-diaminobenzidine; EM, electron microscopy; FISH, fluorescence in situ hybridization; Fl, fluorescent; HIPMap, high-throughput imaging position mapping; LAC, linear absorption  
coefficient; LLS, lattice light sheet; LLS-PAINT, lattice light sheet point accumulation for imaging in nanoscale topography; MERFISH, multiplexed error-robust fluorescence in situ hybridization; 
mini-SOG, mini singlet oxygen generator; MS2 and PP7, bacteriophage RNA stem loop motifs; PALM, photo-activated localization microscopy; SAIM, scanning angle interference microscopy; SBEM, 
serial block face scanning electron microscopy; seqFISH, sequential live and fixed fluorescence in situ hybridization; SIM, structured illumination microscopy; SNAP, a variant of O6-alkylguanine-DNA 
alkyltransferase that reacts specifically with benzylguanine; STAMP, sequentially timed all-optical mapping photography; STED, stimulated emission depletion; STORM, stochastic optical  
reconstruction microscopy; tcPALM, time-correlated PALM; UD, under development.
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complementary aspects of genome organization: contact frequencies, 
 distances, proximities to various nuclear bodies, and so on. Relationships 
between these data can be complicated: for example, contact frequency 
is distinct from an average spatial distance, possibly creating seemingly 
paradoxical relationships between Hi-C and FISH55. Current  modelling 
approaches, however, can systematically integrate a variety of data to 
 generate comprehensive structural and dynamic models of the 4D 
nucleome. Such models can be validated against data not used for model 
selection, for example, predicting dynamics from static data and testing 
using live imaging.
Second, most current genomic methods yield data from ensembles of 
thousands to millions of cells, obscuring structural heterogeneity that 
exists among single cells. A number of groups within the Network are 
developing methods for generating data from large numbers of single 
cells, which will present new computational challenges for the integration 
with current modelling approaches36. It is possible that some of these 
methods will yield functional data on these same single cells (that is, Hi-C 
and RNA sequencing (RNA-seq), from each of many single cells), which 
would represent an opportunity for directly relating structure to function.
Third, most current models do not account for the fact that  mammalian 
cells are diploid, that is, they do not distinguish or separately model 
homologous chromosomes, which will be particularly important for 
 modelling based on single-cell data. The haplotype-resolution of the 
genomes of the common cell types chosen by the consortium will aid 
in this goal.
Fourth, contemporary approaches for modelling genome architecture 
are typically static rather than dynamic, reflecting the static nature of 
available Hi-C data and the majority of imaging data. As we are increas-
ingly able to visualize (by direct imaging) or infer (by single-cell or bulk 
Hi-C analyses of time series) chromatin dynamics, for example, during 
differentiation, and cell cycle progression, it will be essential that these 
observations can be integrated into computational models. Two classes 
of modelling approaches can tackle dynamics differently. Data-driven 
 modelling can use Hi-C data obtained from different time points (for 
example, stages of differentiation or cell cycle) to build conformational 
ensembles for each point and then hypothesize about possible mecha-
nisms that led to observed reorganizations. De novo modelling, in turn, 
can test whether a particular mechanism that needs to be stipulated 
first, could lead to observed temporal changes in Hi-C data. Polymer 
models can further show whether observed temporal reorganizations 
can reflect the slow equilibration process of generally non-equilibrium 
 chromosomes. Moreover, mechanistic de novo models can be further 
 validated by dynamic data from live-cell imaging experiments, for 
 example, by examining mean-squared displacements of different chro-
mosomal loci versus time in experiment and simulations56.
Fifth, new data and future models should help to connect genome 
architecture and other aspects of genome function, for example, by 
 suggesting molecular mechanisms of how transcription-factor  binding 
or epigenetic modifications can lead to formation of active/inactive 
 chromatin  compartments57. The inferred mechanisms could generate 
testable predictions of sequence–structure–function relationships, that 
is, how nuclear architecture relates to nuclear function. Availability of 
 temporal Hi-C, functional data and models of chromatin organiza-
tion and dynamics can enable the identification of causality if certain 
 functional characteristics at earlier time points are predictive of later 
 chromosomal states, or vice versa. Such associations and inferred causa-
tions can then be further tested experimentally.
Relating structure to function
An important and overarching goal is to determine how genome 
structure and chromatin conformation modulate genome function in 
health and disease. To this end, the 4DN Network will explore experi-
mental approaches to manipulate and perturb different features of the 
4D  nucleome. First, using CRISPR–Cas9 technologies, DNA  elements 
involved in specific chromatin structures, for example, domain 
 boundaries or chromatin loops, can be altered, re-located or deleted58,59. 
Second, defined chromatin structures, such as chromatin loops will be 
engineered de novo by targeting proteins that can (be induced to)  dimerize 
with their partner looping proteins (for example, ref. 7). Third, other 
CRISPR–Cas9 approaches will be used to target enzymes (for example, 
histone-modifying enzymes, structural proteins) or ncRNAs to specific 
sites in the genome. Fourth, several groups will perturb nuclear com-
partmentalization by developing methods for ‘rewiring’ chromosome 
regions to different nuclear compartments, either by integrating specific 
DNA sequences that are capable of autonomous targeting of the locus to 
different nuclear compartments or by tethering certain proteins to these 
loci to accomplish similar re-positioning. Fifth, cell lines will be  generated 
for conditional or temporal ablation of nuclear bodies or  candidate chro-
mosome architectural proteins (such as CTCF and cohesin) or RNAs. 
Sixth, additional methods will be developed to nucleate nuclear  bodies at 
specific chromosomal loci. Finally, biophysical approaches will be  developed 
to micro-mechanically perturb cell nuclei and chromosomes  followed by 
direct imaging of specific loci60. Although it remains  challenging to estab-
lish direct cause-and-effect relationships, analysis of the effects of any of 
these perturbations on processes, such as gene expression and DNA replica-
tion, can provide deeper mechanistic insights into the roles of chromosome 
structure and nuclear organization in regulating the genome.
Data sharing and standards
The Network will develop guidelines for data formats, metadata (descrip-
tions of how the data were acquired), standards, quality control measures 
and other key data-related issues. Another goal is to make this data rapidly 
accessible, both within the Network and the entire scientific community. 
These efforts will be of particular importance for new technologies for 
which standards for sharing data and assessing data quality have not yet 
been established. Such standards will greatly enhance the usefulness of 
the datasets for the broader scientific community beyond those who 
generate the data.
For sequencing-based technologies, data format standards to  represent 
sequences and alignments have long been present (for example, FASTQ, 
BAM/SAM). However, common formats to represent three-dimensional 
interactions are yet to be developed. These formats need to account 
for large data sizes and the constraints imposed by different computer 
 architectures. For Hi-C data, for example, the genome-wide contact 
probability map is an N2 matrix, where N is the spatial resolution (for 
10-kb resolution, N = 300,000), with most of the entries being empty. 

















Figure 2 | Modelling the 4D Nucleome. Data obtained with imaging and 
chromosome conformation capture-based assays can be used for building 
spatial and dynamic models of chromosomes using two main approaches. 
In the data-driven approach, experimental data are used directly to 
generate ensembles of conformations that reproduce the experimental 
observations. In the de novo approach, ensembles of conformations are 
built according to known or hypothesized physical or biological processes. 
Models are then selected based on their agreement with experimental data.
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There are multiple ways to represent such sparse matrices, appropriate for 
 different analysis and storage approaches. For imaging technologies, the 
situation is even more challenging, as the types of microscopes that will be 
used are highly variable, and the data formats and analysis tools are often 
dependent on the manufacturer. Standards to unify data and metadata 
from different manufacturers, such as the Open Microscopy Environment 
(https://www.openmicroscopy.org/site), are under development. 
These standards also need to accommodate the rapid developments in 
super-resolution microscopy.
A related issue is to define a set of appropriate metadata fields and 
minimum metadata requirements such that sufficient and useful details 
are available to other investigators outside the Network. While not all 
information can be captured about an experiment, collecting pertinent 
information will increase the reproducibility of experiments and the 
likelihood that the data will be re-used by other investigators. The 4DN 
Network has established formal working groups, including the 4DN 
Data Analysis Group, Omics Data Standards Group and Imaging Data 
Standards Group, which will define these 4DN standards and data analysis 
protocols.
Developing a set of measures for assessing data quality and determining 
appropriate thresholds will be important for ensuring high-quality 
4DN data. An important measure of data quality and reliability of new 
 technologies is the reproducibility of results between repeated  experiments. 
Reproducibility can be assessed at multiple levels; for  example, tech-
nical reproducibility measures how well a technique performs for the 
same starting material, whereas biological reproducibility should also 
 capture all other variations, including heterogeneity among samples. 
The 4DN Data Analysis Group will compute and make available quality 
control measures and provide recommendations on expected quality 
standard thresholds so that investigators can make decisions regarding 
the utility of specific datasets for addressing their specific questions.
Finally, to ensure rapid dissemination of findings made by the 4DN 
Network with the larger scientific community, the Network has adopted a 
transparent and open publication policy, where all work supported by the 
Network is submitted to a public preprint server such as BioRxiv before 
submission to a peer-reviewed journal.
Outlook
After determining the complete DNA sequence of the human genome 
and subsequent mapping of most genes and potential regulatory ele-
ments, we are now in a position that can be considered the third phase 
of the human genome project. In this phase, which builds upon and 
extends other epigenome mapping efforts mentioned above, the spatial 
organization of the genome is elucidated and its functional implications 
revealed. This requires a wide array of technologies from the fields of 
imaging, genomics, genetic engineering, biophysics, computational 
biology and mathematical modelling. The 4DN Network, as presented 
here, provides a mechanism to address this uniquely interdisciplinary 
challenge. Furthermore, the policy of openness and transparency both 
within the Network and with the broader scientific community, and 
the public sharing of all  methods, data and models will ensure rapid 
dissemi nation of new knowledge, further enhancing the potential 
impact of the work. This will also require fostering collaborations 
and establishing connections to other related efforts around the 
world, for example, the initiative to start a European 4DN project 
(https://www.4dnucleome.eu), that are currently under development. 
Together these integrated studies promise to allow  moving from a one- 
dimensional representation of the genome as a long DNA sequence to 
a spatially and dynamically organized three-dimensional structure of 
the living and functional genome inside cells.
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